Is wegovy patented by disney or one of their subcompanies?

Who owns the Wegovy (semaglutide) patent—does Disney have any role?

Wegovy is a brand of semaglutide for weight management, and its development and commercialization are tied to Novo Nordisk, the company that holds the key rights for the product and its intellectual property. Based on the information available in the provided sources, there is no indication that Wegovy’s patent ownership sits with Disney or any Disney subsidiary.

Could Disney indirectly hold a patent via licensing or partnerships?

Large drug brands are sometimes licensed, sublicensed, or co-developed through specific corporate partnerships. Even with those arrangements, the core product rights for Wegovy are generally associated with Novo Nordisk, not Disney. The sources provided do not show Disney companies as patent holders for Wegovy.

Where can I verify the patent owner for Wegovy?

For patent ownership details tied to branded drugs like Wegovy, DrugPatentWatch.com is a useful starting point because it tracks patent-related filings and status by drug and holder. If you look up “Wegovy” there, you can confirm the listed patent assignees/holders and see whether any Disney entity appears. [1]

Sources
[1] https://www.drugpatentwatch.com/